Comparison of oxaliplatin and paclitaxel-induced neuropathy (Alliance A151505)
      QxMD      Google Scholar   
Citation:
Support Care Cancer vol 24 (12) 5059-5068
Year:
2016
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pmc-release
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
6
Parents:
2265  
Children:
None
Program:
CCP
Primary Committee:
Symptom Inter
Sec. Committees:
Health Outcomes    
Pharmas:
 
Grants:
U10 CA035267, U10 CA052352, U10 CA037417, U10 CA035269, K05 CA124477, U10 CA037404, U10 CA180858, U10 CA063848, U10 CA035272, U10 CA035101, UG1 CA189823, U10 CA035113, U10 CA035415, U10 CA180882, R01 CA200263, U10 CA035431, U10 CA025224, U10 CA035090, U10 CA063844, U10 CA035103  
Corr. Author:
 
Authors:
                                 
Networks:
LAPS-MD017, LAPS-MN026   
Study
Alliance-A151505
Multiple Studies, or Legacy Studies in Alliance Study:
NCCTG-N08C1, NCCTG-N08CB
Phases:
N/A, 3, N/A
Keywords:
Chemotherapy-induced peripheral neuropathy, Oxaliplatin neuropathy, Paclitaxel neuropathy